Mobile Health Exercise Regimen for Heart Valve Disease
(HOMERUNHITTER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist individuals who have undergone transcatheter heart valve interventions (a procedure to repair heart valves without open-heart surgery) in improving their heart health at home. It evaluates a home-based cardiac rehabilitation program using a mobile app to promote healthy behaviors and monitor progress. Participants are divided into groups to receive either a standard care guide, a hands-off app-based program, or an interactive app-based program with video support. The study examines how these methods affect physical activity, quality of life, and health outcomes. Individuals who have had a heart valve procedure through the leg and do not plan to join a traditional rehab program might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to explore innovative rehabilitation methods for enhanced heart health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this mobile health exercise regimen is safe for heart valve disease patients?
Research has shown that home-based cardiac rehabilitation (HBCR) is generally safe for people with heart conditions. Studies have found a very low risk of unwanted side effects during HBCR, allowing most people to participate in these programs at home without major issues.
Some research suggests that people who engage in HBCR may have fewer hospital visits compared to those attending center-based programs. This indicates that HBCR not only aids recovery but also promotes long-term health.
Overall, evidence supports that most patients tolerate HBCR well, which might reassure anyone considering joining a trial involving this type of home-based program.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Health Exercise Regimen for Heart Valve Disease because it offers a new way to do cardiac rehabilitation from home. Unlike traditional cardiac rehab, which often requires visits to a medical center, this approach uses a mobile app to guide patients through their exercises. The "HBCR interactive" group adds an extra layer of support with video calls from exercise physiologists, which could make rehab more personalized and engaging. Both approaches aim to make cardiac rehab more accessible and convenient, potentially leading to better outcomes for patients who can't easily access traditional rehab programs.
What evidence suggests that this trial's treatments could be effective for heart valve disease?
Research has shown that cardiac rehabilitation exercises at home can be as effective as attending a rehab center for people with heart disease. In this trial, participants will be assigned to different approaches to home-based cardiac rehabilitation (HBCR). One group will follow the HBCR hands-off approach, using a mobile application and AHA Life's Essential 8 sheets. Another group will participate in the HBCR interactive approach, which includes periodic video calls with an exercise physiologist in addition to the mobile application and AHA Life's Essential 8 sheets. Studies have found that home-based rehab can improve physical fitness and help people adhere to their exercise routines better than not doing rehab at all. Many who choose home-based rehab report greater satisfaction and are more likely to maintain their exercises. Some research even suggests that mobile apps and digital tools can enhance the effectiveness of home-based rehab. Overall, home-based rehab appears to be a good option for those who can't or don't want to attend a rehab center.36789
Who Is on the Research Team?
Brian R. Lindman, MD
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for heart valve disease patients who've had a transcatheter heart valve intervention via the leg. They must be able to use an activity tracker, not planning on joining center-based rehab, and capable of using digital tools without physical or mental limitations that would interfere.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Roll-in
Brief roll-in period before randomization
Treatment
Participants receive home-based cardiac rehabilitation using a mobile app, randomized to either hands-off or interactive delivery for 12 or 24 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Home-Based Cardiac Rehabilitation
Home-Based Cardiac Rehabilitation is already approved in European Union, United States, Canada for the following indications:
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
- Coronary artery disease
- Heart failure
- Post-myocardial infarction rehabilitation
- Post-percutaneous coronary intervention rehabilitation
- Post-coronary artery bypass grafting rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
Wake Forest University Health Sciences
Collaborator
Morristown Medical Center
Collaborator
Piedmont Healthcare
Collaborator
Inova Fairfax Hospital
Collaborator
Chattanooga-Hamilton County Hospital Authority
Collaborator
Medical University of South Carolina
Collaborator
Duke Clinical Research Institute
Collaborator
University of Michigan
Collaborator
Pinnacle Health Cardiovascular Institute
Collaborator